REGIONAL EXTRACTION OF ENDOTHELINS AND CONVERSION OF BIG ENDOTHELIN TO ENDOTHELIN-1 IN THE PIG

被引:37
作者
HEMSEN, A
PERNOW, J
LUNDBERG, JM
机构
[1] Department of Pharmacology, Karolinska Institutet, Box 60400
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 1991年 / 141卷 / 03期
关键词
CLEARANCE; ENDOTHELIN; KIDNEY; SARAFOTOXIN; 6B; SPLEEN; VASOCONSTRICTION;
D O I
10.1111/j.1748-1716.1991.tb09088.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Endothelin-like immunoreactivity (ET-LI), mean arterial blood pressure (MABP) and vascular resistance in the spleen, kidney and femoral vascular bed were measured during intravenous infusions (20 pmol.kg-1.min) of endothelin-2 (ET-2), endothelin-3 (ET-3), big endothelin-1 (big ET) and sarafotoxin 6b in the pig. All peptides (especially endothelin-2 and sarafotoxin 6b) caused vasoconstrictor effects in the kidney. Endothelin-2, endothelin-3 and sarafotoxin 6b also evoked significant increases in splenic and femoral vascular resistance. The relative vasoconstrictor response to endothelin-2 was larger in the kidney and spleen than in the femoral vascular bed whereas the opposite was observed for endothelin-3. A high degree of plasma clearance for endothelin-like immunoreactivity was observed. Thus, for ET-2 and ET-3 about 70% of arterial endothelin-like immunoreactivity was removed over the kidney while over the spleen and femoral vascular bed an extraction of 50% for plasma endothelin-2 and 30-40% for endothelin-3 was observed. Big endothelin-1 was only extracted by 34% over the kidney and not at all in the splenic or femoral vascular bed. The metabolic plasma half-lifes of endothelin-2 and endothelin-3 in vivo were in the same range, 1-2 minutes, whereas the half-life of big endothelin-1 was 9 minutes. HPLC-characterization of the plasma endothelin-like immunoreactivity during and after big endothelin-1-infusion as well as measurements using a specific endothelin-1 antiserum revealed formation of endothelin-1 from circulating big endothelin-1 in vivo but not in plasma in vitro. It is concluded that there exists specificity concerning the vasoconstrictor effects and the removal of endothelin-peptides from the circulation, both mechanisms being most prominent in the kidney. Big endothelin-1 has a much longer metabolic half-life, less regional clearance and poor vasoconstrictor activity compared with endothelin-1. Furthermore, endothelin-1 is formed from circulating big endothelin-1 probably by an endothelin-converting enzyme.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 17 条
[1]  
DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
[2]   ANTIBODIES TO BRADYKININ + ANGIOTENSIN - USE OF CARBODIIMIDES IN IMMUNOLOGY [J].
GOODFRIEND, TL ;
LEVINE, L ;
FASMAN, GD .
SCIENCE, 1964, 144 (362) :1344-&
[3]   CHARACTERIZATION OF A CORONARY VASOCONSTRICTOR PRODUCED BY CULTURED ENDOTHELIAL-CELLS [J].
HICKEY, KA ;
RUBANYI, G ;
PAUL, RJ ;
HIGHSMITH, RF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (05) :C550-C556
[4]   CELLULAR MECHANISM OF ACTION BY A NOVEL VASOCONSTRICTOR ENDOTHELIN IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
HIRATA, Y ;
YOSHIMI, H ;
TAKATA, S ;
WATANABE, TX ;
KUMAGAI, S ;
NAKAJIMA, K ;
SAKAKIBARA, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) :868-875
[5]   THE HUMAN ENDOTHELIN FAMILY - 3 STRUCTURALLY AND PHARMACOLOGICALLY DISTINCT ISOPEPTIDES PREDICTED BY 3 SEPARATE GENES [J].
INOUE, A ;
YANAGISAWA, M ;
KIMURA, S ;
KASUYA, Y ;
MIYAUCHI, T ;
GOTO, K ;
MASAKI, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2863-2867
[6]   CONVERSION OF BIG ENDOTHELIN-1 TO 21-RESIDUE ENDOTHELIN-1 IS ESSENTIAL FOR EXPRESSION OF FULL VASOCONSTRICTOR ACTIVITY - STRUCTURE ACTIVITY RELATIONSHIPS OF BIG ENDOTHELIN-1 [J].
KIMURA, S ;
KASUYA, Y ;
SAWAMURA, T ;
SHINMI, O ;
SUGITA, Y ;
YANAGISAWA, M ;
GOTO, K ;
MASAKI, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S5-S7
[7]   ABUNDANCE OF ENDOTHELIN-3 IN RAT INTESTINE, PITUITARY-GLAND AND BRAIN [J].
MATSUMOTO, H ;
SUZUKI, N ;
ONDA, H ;
FUJINO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (01) :74-80
[8]   INCREASED PLASMA-CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL-INFARCTION [J].
MIYAUCHI, T ;
YANAGISAWA, M ;
TOMIZAWA, T ;
SUGISHITA, Y ;
SUZUKI, N ;
FUJINO, M ;
AIISAKA, R ;
GOTO, K ;
MASAKI, T .
LANCET, 1989, 2 (8653) :53-54
[9]   ENDOTHELIN-1 RECEPTORS IN RAT RENAL GLOMERULI [J].
ORITA, Y ;
FUJIWARA, Y ;
OCHI, S ;
TAKAMA, T ;
FUKUNAGA, M ;
YOKOYAMA, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S159-S161
[10]   TISSUE SPECIFIC DISTRIBUTION, CLEARANCE AND VASCULAR EFFECTS OF ENDOTHELIN IN THE PIG [J].
PERNOW, J ;
HEMSEN, A ;
LUNDBERG, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :647-653